Swadeshi vaccine to counter anthrax
A swadeshi vaccine to counter anthrax is expected to hit the markets early next year. And unlike the one used in USA, the Indian pharmaceutical company that has bought rights for the recombinant
A swadeshi vaccine to counter anthrax is expected to hit the markets early next year. And unlike the one used in USA, the Indian pharmaceutical company that has bought rights for the recombinant